Elevated total FGF23 levels have previously been shown to be associated with increased risk of death in RTRs, as well as in various other patient groups including postoperative acute kidney injury, nondialysis CKD, and ESRD [31,32,33,34,35]. The gene discussed is FGF23; the disease is acute kidney injury.